Medi-Cal will continue to cover GLP-1s when used for FDA-approved, non-weight-loss indications (e.g., type 2 diabetes, ASCVD, CKD) with appropriate ICD-10 codes and, when required, prior authorization
Of course, when a new weight loss option starts to become popular, understandably, everyone wants to know if it is safe
Glucagon-like peptide-1 and its class B G protein-coupled receptors: A long march to therapeutic successes
The most commonly reported effects include nausea, vomiting, diarrhea, and abdominal discomfort, which often improve over time
Reviewed by the PeptideMind Team Updated July 6th, 2026 Free Peptide Blend Calculator Calculate exact draw volumes for peptide blends, stacks, and custom multi-peptide preparations